MASLD was present in 50% of patients and independently associated with early respiratory failure (OR 3.8) and vasopressor-dependent shock (OR 4.0), despite similar sCAP severity at baseline. Here, SCAP is linked to metabolic dysfunction-associated steatotic liver disease.